Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 8,829 TXG shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | 10x Genomics, Inc. (TXG) | Grant/Award | 8,829 | n/a |
| Jun 5, 2025 | 10x Genomics, Inc. (TXG) | Grant/Award | 15,357 | n/a |
| Oct 2, 2024 | NEVRO CORP (NVRO) | Grant/Award | 2,817 | n/a |
| Jul 2, 2024 | NEVRO CORP (NVRO) | Grant/Award | 1,870 | n/a |
| Jun 13, 2024 | 10x Genomics, Inc. (TXG) | Grant/Award | 8,649 | n/a |
| May 28, 2024 | NEVRO CORP (NVRO) | Grant/Award | 19,169 | n/a |
| Apr 2, 2024 | NEVRO CORP (NVRO) | Grant/Award | 1,090 | n/a |
| Jun 16, 2023 | 10x Genomics, Inc. (TXG) | Grant/Award | 1,865 | n/a |
| Sep 16, 2022 | 10x Genomics, Inc. (TXG) | Exercise/Conversion | 10,000 | $114.8K |
| Jun 17, 2022 | 10x Genomics, Inc. (TXG) | Grant/Award | 2,120 | n/a |